Nephros Statistics
Total Valuation
Nephros has a market cap or net worth of $18.23 million. The enterprise value is $15.88 million.
Important Dates
The last earnings date was Monday, March 24, 2025.
Earnings Date | Mar 24, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Nephros has 10.60 million shares outstanding. The number of shares has increased by 2.08% in one year.
Current Share Class | 10.60M |
Shares Outstanding | 10.60M |
Shares Change (YoY) | +2.08% |
Shares Change (QoQ) | -0.24% |
Owned by Insiders (%) | 12.80% |
Owned by Institutions (%) | 44.59% |
Float | 9.24M |
Valuation Ratios
The trailing PE ratio is 244.67 and the forward PE ratio is 86.00.
PE Ratio | 244.67 |
Forward PE | 86.00 |
PS Ratio | 1.28 |
Forward PS | 1.19 |
PB Ratio | 2.11 |
P/TBV Ratio | 2.51 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 214.64 |
EV / Sales | 1.12 |
EV / EBITDA | 111.07 |
EV / EBIT | 2,647.27 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.31, with a Debt / Equity ratio of 0.16.
Current Ratio | 5.31 |
Quick Ratio | 3.55 |
Debt / Equity | 0.16 |
Debt / EBITDA | 2.02 |
Debt / FCF | n/a |
Interest Coverage | 6.00 |
Financial Efficiency
Return on equity (ROE) is 0.87% and return on invested capital (ROIC) is 0.04%.
Return on Equity (ROE) | 0.87% |
Return on Assets (ROA) | 0.03% |
Return on Invested Capital (ROIC) | 0.04% |
Return on Capital Employed (ROCE) | 0.06% |
Revenue Per Employee | $456,839 |
Profits Per Employee | $2,387 |
Employee Count | 31 |
Asset Turnover | 1.23 |
Inventory Turnover | 2.14 |
Taxes
In the past 12 months, Nephros has paid $15,000 in taxes.
Income Tax | 15,000 |
Effective Tax Rate | 16.85% |
Stock Price Statistics
The stock price has decreased by -21.46% in the last 52 weeks. The beta is 1.20, so Nephros's price volatility has been higher than the market average.
Beta (5Y) | 1.20 |
52-Week Price Change | -21.46% |
50-Day Moving Average | 1.57 |
200-Day Moving Average | 1.72 |
Relative Strength Index (RSI) | 62.34 |
Average Volume (20 Days) | 10,540 |
Short Selling Information
The latest short interest is 19,379, so 0.18% of the outstanding shares have been sold short.
Short Interest | 19,379 |
Short Previous Month | 8,342 |
Short % of Shares Out | 0.18% |
Short % of Float | 0.21% |
Short Ratio (days to cover) | 1.18 |
Income Statement
In the last 12 months, Nephros had revenue of $14.16 million and earned $74,000 in profits. Earnings per share was $0.01.
Revenue | 14.16M |
Gross Profit | 8.72M |
Operating Income | 6,000 |
Pretax Income | -1.29M |
Net Income | 74,000 |
EBITDA | 143,000 |
EBIT | 6,000 |
Earnings Per Share (EPS) | $0.01 |
Full Income Statement Balance Sheet
The company has $3.76 million in cash and $1.41 million in debt, giving a net cash position of $2.35 million or $0.22 per share.
Cash & Cash Equivalents | 3.76M |
Total Debt | 1.41M |
Net Cash | 2.35M |
Net Cash Per Share | $0.22 |
Equity (Book Value) | 8.59M |
Book Value Per Share | 0.81 |
Working Capital | 6.74M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$492,000 and capital expenditures -$55,000, giving a free cash flow of -$547,000.
Operating Cash Flow | -492,000 |
Capital Expenditures | -55,000 |
Free Cash Flow | -547,000 |
FCF Per Share | -$0.05 |
Full Cash Flow Statement Margins
Gross margin is 61.59%, with operating and profit margins of 0.04% and 0.52%.
Gross Margin | 61.59% |
Operating Margin | 0.04% |
Pretax Margin | 0.63% |
Profit Margin | 0.52% |
EBITDA Margin | 1.01% |
EBIT Margin | 0.04% |
FCF Margin | n/a |
Dividends & Yields
Nephros does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.08% |
Shareholder Yield | -2.08% |
Earnings Yield | 0.41% |
FCF Yield | -3.00% |
Analyst Forecast
The average price target for Nephros is $5.00, which is 190.70% higher than the current price. The consensus rating is "Buy".
Price Target | $5.00 |
Price Target Difference | 190.70% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on July 10, 2019. It was a reverse split with a ratio of 0.1111111:1.
Last Split Date | Jul 10, 2019 |
Split Type | Reverse |
Split Ratio | 0.1111111:1 |
Scores
Nephros has an Altman Z-Score of -10.76 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -10.76 |
Piotroski F-Score | 4 |